Published in the Journal of the American Medical Association (JAMA), the letter says that the dismissal of the advisors and the appointment of eight new ACIP members two days later, along with ...

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.